Okay.
On existing tax subsidies, your report indicated the fact that because “the federal government does not include benefits received” by employees from employer-sponsored health care plans in an employee's taxable income, it is an indirect tax subsidy. I think you estimated that at about “$2,605 million in 2016”.
Would I be correct in assuming that if we went to a system that cancelled those existing tax subsidies under national pharmacare, it could be a source of additional savings to the government? Do I have that right?